PlateReady™ A549 96 Well Medium Confluency (40 - 60%) - (20cmLx12cmWx3cmH, weigh t50g)
| PlateReady™ A549 96-Well Plates contain adherent human lung carcinoma epithelial cells cryopreserved directly adhered to 96-well plates with the use of CryoLogyx’s patented CryoShield™ formulation. PlateReady™ A549 is a well-characterized cell line that has been widely used to model lung cancer and type II alveolar epithelium. The efficacy of drug therapies and delivery systems can be determined using A549 cells. PlateReady™ A549 Well Plates are compatible with all major assays just 24 hours after thawing. |
|
|
Over 80% cell viability is expected post-thaw, with cells retaining healthy morphology. |
|
|
Content Cryopreserved adherent A549 cells in a 96-well plate. Each well contains 100 µL of CryoLogyx’s proprietary cryoprotectant formulation. No cells are present in rows A and H and columns 1 and 12 to avoid assay edge effects (blue on diagram). Storage -80°C Freezer. Use by the expiry date on the packagingThawing and culturing medium F-12K Medium (Kaighn's Modification of Ham's F-12 Medium) supplemented with 10% fetal bovine serum and 1% antibiotic-antimyotic solution (optional). |
